Back
Grupo Financiero Banorte SAB de CV Vs. Neurogene Industry Stock Comparison
Sell
43
GBOOF
Grupo Financiero Banorte SAB de CV
Last Price:
6.84
Seasonality Move:
5.95%
Sell
5
NGNE
Neurogene
Last Price:
39.96
Seasonality Move:
50.43%
Sell
43
Grupo Financiero Banorte SAB de CV (GBOOF)
is a Sell
Is Grupo Financiero Banorte SAB de CV a Buy, Sell or Hold?
- The current Grupo Financiero Banorte SAB de CV [GBOOF] share price is $6.84. The Score for GBOOF is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- GBOOF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
5
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $39.54. The Score for NGNE is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
GBOOF Stock Price Chart
What is Grupo Financiero Banorte SAB de CV's stock price today?
-
The Grupo Financiero Banorte SAB de CV share price today is $6.84
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GBOOF is experiencing selling pressure, which indicates risk of future bearish movement.
GBOOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 45.27 | Sell |
Chaikin Money Flow: | -3268 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.83 - 7.51) | Sell |
Bollinger Bands (100): | (6.94 - 8.04) | Sell |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.3 | Buy |
Relative Strength Index (14 RSI): | 39.1 | Sell |
Chaikin Money Flow: | -346626 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.29 - 61.53) | Sell |
Bollinger Bands (100): | (34.11 - 50.51) | Sell |
GBOOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.02 | Sell |
20-day SMA: | 7.08 | Sell |
50-day SMA: | 7.23 | Sell |
200-day SMA: | 8.78 | Sell |
8-day EMA: | 7.01 | Sell |
20-day EMA: | 7.09 | Sell |
50-day EMA: | 7.26 | Sell |
200-day EMA: | 8.17 | Sell |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 60.39 | Sell |
20-day SMA: | 53.17 | Sell |
50-day SMA: | 46.66 | Sell |
200-day SMA: | 38.93 | Buy |
8-day EMA: | 54.03 | Sell |
20-day EMA: | 53.18 | Sell |
50-day EMA: | 48.36 | Sell |
200-day EMA: | 38.47 | Buy |
Grupo Financiero Banorte SAB de CV Earnings Growth & GBOOF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
Grupo Financiero Banorte SAB de CV Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |